Tan, Eng M.
September 1976
Journal of Investigative Dermatology;Sep76, Vol. 67 Issue 3, p360
Academic Journal
A striking feature of systemic lupus erythematosus (SLE) has been the cutaneous involvement in this disease, which is manifested as an erythematous, macular-papular rash scattered on various parts of the body but especially on the sun-exposed surfaces. Since SLE is characterized so strikingly by immunologic abnormalities, it was apparent to many investigators that studies of the skin lesions with immunologic techniques might provide useful information regarding some of the pathogenetic mechanisms controlling disease activity.


Related Articles

  • Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus. Katsiari, Christina G.; Kyttaris, Vasileios C.; Yuang-Taung Juang; Tsokos, George C.; Juang, Yuang-Taung // Journal of Clinical Investigation;Nov2005, Vol. 115 Issue 11, p3193 

    Decreased IL-2 production in systemic lupus erythematosus (SLE) represents a central component of the disease immunopathology. We report that the message, protein, and enzymatic activity of the catalytic subunit of protein phosphatase 2A (PP2Ac), but not PP1, are increased in patients with SLE...

  • Fever and Rash. Brown, Monica L.; Chesney, P. Joan; Ault, Bettina H.; Santos, Noel M. Delos; Truong, Luan D.; Lohr, Kristine M.; Myers, Linda K. // Clinical Pediatrics;Jul2008, Vol. 47 Issue 6, p610 

    The article presents information on a study examining a case of systemic lupus erythematosus (SLE) that was masked by an infection with human monocytic ehrlichiosis (HME). It is reported that HME due to infection by the rickettsia E chaffeensis can be difficult to diagnose because its symptoms...

  • TREATMENT ADHERENCE AND CLINICAL OUTCOME IN SYSTEMIC LUPUS ERYTHEMATOSUS. Chambers, S. A.; Rahman, A.; Isenberg, D. A. // Romanian Journal of Rheumatology;2008, Vol. 17 Issue 1, p10 

    The adherence to the treatment, that is the tenacity and the consistency with which the patient respects his personal doctor's indications, are decisive factors for the evolution of chronic diseases, especially of those with low prognosis. Authors review the paper works dedicated to this subject...

  • Fatal Kikuchi—Fujimoto disease associated with SLE and hemophagocytic syndrome: a case report. Kampitak, Thatchai // Clinical Rheumatology;Aug2008, Vol. 27 Issue 8, p1073 

    Kikuchi–Fujimoto disease (KFD) or histiocytic necrotizing lymphadenitis is a rare, benign, autoimmune condition characterized by lymphadenopathy, fever, and neutropenia. KFD can frequently mimic various diseases including infection, malignancy, and autoimmune disease. KFD has also been...

  • PRELIMINARY ANNOUNCEMENT.  // Journal of Investigative Dermatology;May90, Vol. 94 Issue 5, p643 

    The III International Conference on systemic lupus erythematosus will be held in the Queen Elizabeth II Conference Centre, Westminster, London, England on April 13-15, 1992. Further information can be obtained from Graham Hughes or Denzil Fletcher of the Rheumatology Department, St. Thomas'...

  • Prasterone for women with SLE receiving glucocorticoids.  // Reactions Weekly;9/3/2005, Issue 1067, p4 

    Discusses research being done on the effectiveness of prasterone in women with systemic lupus erythematosus (SLE) receiving glucocoticoids. Reference to a study by Genelabs Technologies Inc. released on August 18, 2005; Benefits of prasterone to women with SLE.

  • Protein-losing enteropathy associated with systemic lupus erythematosus: response to cyclophosphamide. Werner de Castro, Gláucio R.; Appenzeller, Simone; Bértolo, Manoel B.; Costallat, Lílian Tereza Lavras // Rheumatology International;Mar2005, Vol. 25 Issue 2, p135 

    Protein-losing enteropathy is a rare manifestation of systemic lupus erythematosus (SLE) leading to hypoalbuminemia and anasarca. We report the case of a woman with SLE who presented chronic hypoalbuminemia diagnosed as protein-losing enteropathy associated with SLE. She was refractory to...

  • Hypercalcaemia in Systemic Lupus Erythematosus. Berar-Yanay, N.; Weiner, P.; Magadle, R. // Clinical Rheumatology;Mar2001, Vol. 20 Issue 2, p147 

    : Hypercalcaemia is a common electrolyte abnormality. The vast majority of patients will be shown to have either hyperparathyroidism or malignancy. In less than 10% of patients other, less common causes of hypercalcaemia will be present. Systemic lupus erythematosus is a very rare cause of...

  • Outcome of patients with systemic lupus erythematosus in intensive care unit. Alzeer, A. H.; Al-Arfaj, A.; Basha, S. J.; Alballa, S.; Al-Wakeel, J.; Al-Arfaj, H.; Al-Sugair, S.; Al-Mugeiren, S.; Al-Shamairi, M.; Bamgboye, E. A. // Lupus;2004, Vol. 13 Issue 7, p537 

    The objective of the study was to identify the causes, outcome and prognosis of severe illness in patients with systemic lupus erythematosus (SLE) requiring intensive care unit (ICU) care in a University Hospital over a five-year period. The design was a cohort study. Forty-eight SLE patients...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics